Unveiling the Power of Pharmaceutical Sciences from Molecules to Medicines
Article Sidebar
Molecules,
Medicines
Main Article Content
Abstract
Precision Medicine is a notable development in the field, representing a significant departure from traditional approaches. This novel approach involves the customization of therapeutic interventions based on an individual's unique genetic and molecular profile. The integration of pharmaceutical sciences and Precision Medicine holds great potential to transform the field of healthcare by providing therapeutic interventions that optimize effectiveness while mitigating potential risks. Pharmaceutical formulations and dosage design are fundamental components of medication administration. The landscape of medication administration is being redefined by the emergence of novel drug delivery technologies. Nanotechnology, sustained-release formulations, and implantable devices present innovative strategies for drug targeting, absorption, and release, thereby holding potential for personalized, efficient, and patient-centric therapeutic interventions. Pharmacovigilance and post-market surveillance encompass the comprehensive monitoring of adverse effects and safety concerns, extending beyond the mere approval of drugs. The safeguarding process in place ensures that the advantages of medications consistently surpass potential risks, thereby enhancing the overall well-being of patients.
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Davies, K. (2015). The $1,000 genome: the revolution in DNA sequencing and the new era of personalized medicine. Simon and Schuster.
Krzyszczyk, P., Acevedo, A., Davidoff, E. J., Timmins, L. M., Marrero-Berrios, I., Patel, M., ... & Yarmush, M. L. (2018). The growing role of precision and personalized medicine for cancer treatment. Technology, 6(03n04), 79-100.
Luciano, J. S., Andersson, B., Batchelor, C., Bodenreider, O., Clark, T., Denney, C. K., ... & Dumontier, M. (2011, December). The Translational Medicine Ontology and Knowledge Base: driving personalized medicine by bridging the gap between bench and bedside. In Journal of biomedical semantics (Vol. 2, No. 2, pp. 1-21). BioMed Central.
MacDougall, D., & Crummett, W. B. (1980). Guidelines for data acquisition and data quality evaluation in environmental chemistry. Analytical Chemistry, 52(14), 2242-2249.
Mostafavi, E., Soltantabar, P., & Webster, T. J. (2019). Nanotechnology and picotechnology: a new arena for translational medicine. In Biomaterials in translational medicine(pp. 191-212). Academic Press.
Sahlgren, C., Meinander, A., Zhang, H., Cheng, F., Preis, M., Xu, C., ... & Sandler, N. (2017). Tailored approaches in drug development and diagnostics: from molecular design to biological model systems. Advanced Healthcare Materials, 6(21), 1700258.
Scahill, S., Harrison, J., Carswell, P., & Babar, Z. U. D. (2009). Organisational culture: an important concept for pharmacy practice research. Pharmacy world & science, 31, 517-521.
Tucker, J. B. (Ed.). (2012). Innovation, dual use, and security: managing the risks of emerging biological and chemical technologies. MIT press.
Waheed, S., Li, Z., Zhang, F., Chiarini, A., Armato, U., & Wu, J. (2022). Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery. Journal of Nanobiotechnology, 20(1), 395.
World Health Organization. (2015). Tracking universal health coverage: first global monitoring report. World Health Organization.